{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:07:07Z","timestamp":1790262427599,"version":"4.1.0"},"reference-count":58,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100000002","name":"the National Institutes of Health grants","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,3,4]]},"DOI":"10.1080\/14656566.2022.2030705","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T10:03:28Z","timestamp":1643018608000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["An evaluation of relugolix\/estradiol\/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women"],"prefix":"10.1080","volume":"23","author":[{"given":"Mohamed","family":"Ali","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt"},{"name":"Center of Drug Discovery Research and Development, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yuan","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fen","family":"Chiang","sequence":"additional","affiliation":[{"name":"School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A","family":"Badary","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Practice Department, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2888-2618","authenticated-orcid":false,"given":"Shih-Min","family":"Hsia","sequence":"additional","affiliation":[{"name":"School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan"},{"name":"Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan"},{"name":"School of Food and Safety, Taipei Medical University, Taipei, Taiwan"},{"name":"Nutrition Research Center, Taipei Medical University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.02.016"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2018.1417381"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168483"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000578"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1900726"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz227"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-020-10075-w"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01105-0"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.05.006"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002933"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904351"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003869"},{"issue":"8","key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jama.2020.13960","article-title":"Elagolix reduces fibroid-related heavy menstrual bleeding long-term","volume":"324","author":"Slomski A","year":"2020","unstructured":"Slomski A. Elagolix reduces fibroid-related heavy menstrual bleeding long-term. Jama. 2020;324(8):733.","journal-title":"Jama"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S185023"},{"key":"e_1_3_4_17_1","article-title":"Highlights on medical treatment of uterine fibroids","volume":"27","author":"Angioni S","year":"2021","unstructured":"Angioni S, D\u2019Alterio MN, Daniilidis A. Highlights on medical treatment of uterine fibroids. Curr Pharm Des. 2021;27(36):3821-3832.","journal-title":"Curr Pharm Des"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S147318"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/10600280211015987"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2021.0152"},{"key":"e_1_3_4_21_1","unstructured":"Pfizer Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE\u00ae the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids. [cited 2022 Jan. Available from: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/myovant-sciences-and-pfizer-receive-fda-approval-myfembreer 2021."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2019.44.2.2927590"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm200216q"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2019.55.8.3020179"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2770"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2013.12.001"},{"key":"e_1_3_4_27_1","unstructured":"EMEA-002428-PIP02-18. Relugolix\/estradiol\/ norethisterone acetate. European Medicines Agency 2019. Last accessed Oct 2021 https:\/\/file.wuxuwang.com\/ema\/ryeqo-epar-public-assessment-report_en.pdf"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041568"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06059"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2020-200619"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.12.011"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04143.x"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2000.00042.x"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0192"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2007.09.025"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2018.1461840"},{"key":"e_1_3_4_37_1","unstructured":"Clinicaltrial.gov. Study of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female Participants. 2021. Last accessed Oct 2021. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04978688"},{"key":"e_1_3_4_38_1","article-title":"Pharmacokinetics, pharmacodynamics, and safety of relugolix, a potent oral once-daily gonadotropin-releasing hormone (GnRH) receptor antagonist, as monotherapy and in combination with estradiol\/norethindrone acetate add-back therapy","volume":"32","author":"Lukes A","year":"2017","unstructured":"Lukes A, Johnson B, Jones L, et al. Pharmacokinetics, pharmacodynamics, and safety of relugolix, a potent oral once-daily gonadotropin-releasing hormone (GnRH) receptor antagonist, as monotherapy and in combination with estradiol\/norethindrone acetate add-back therapy. Hum Reprod. 2017;32:i267\u2010i268.","journal-title":"Hum Reprod"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000514919.44544.95"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003141"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.07.013"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008283"},{"issue":"3","key":"e_1_3_4_44_1","article-title":"Liberty: long-term extension study demonstrating one-year efficacy and safety of relugolix combination therapy in women with symptomatic uterine","volume":"114","author":"Al-Hendy A","year":"2021","unstructured":"Al-Hendy A, Andrea S, Lukes AP, et al. Liberty: long-term extension study demonstrating one-year efficacy and safety of relugolix combination therapy in women with symptomatic uterine. Fertil Steril. 2021;114(3). https:\/\/www.fertstert.org\/article\/S0015-0282(20)30781-0\/fulltext#relatedArticles","journal-title":"Fertil Steril"},{"key":"e_1_3_4_45_1","unstructured":"clinicaltrials.gov. Study of relugolix alone and relugolix combined with hormonal add-back therapy in healthy premenopausal female participants. 2021; Available from: www.clinicaltrials.gov"},{"key":"e_1_3_4_46_1","unstructured":"Clinical Trials_clincosm. [cited 2022 Jan. Available from: https:\/\/www.clincosm.com\/"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.07.014"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxab268"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.07.038"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.12.002"},{"key":"e_1_3_4_52_1","unstructured":"(EMA) E.M.A. Ulipristal acetate for uterine fibroids: EMA recommends restricting use. 2020. Oct 2021. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/ulipristal-acetate-5mg-medicinal-products"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004325"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.4103\/aja.aja_77_20"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.02.114"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2021.1957830"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-016-4078-x"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2014.904850"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2020.1832461"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00174"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051479"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.11.004"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2030705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:41:03Z","timestamp":1732092063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2030705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3,4]]}},"alternative-id":["10.1080\/14656566.2022.2030705"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2030705","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}